144 related articles for article (PubMed ID: 15652789)
1. Effect of antitubercular drugs on dipalmitoylphosphatidylcholine monolayers: implications for drug loaded surfactants.
Chimote G; Banerjee R
Respir Physiol Neurobiol; 2005 Jan; 145(1):65-77. PubMed ID: 15652789
[TBL] [Abstract][Full Text] [Related]
2. Lung surfactant dysfunction in tuberculosis: effect of mycobacterial tubercular lipids on dipalmitoylphosphatidylcholine surface activity.
Chimote G; Banerjee R
Colloids Surf B Biointerfaces; 2005 Nov; 45(3-4):215-23. PubMed ID: 16198543
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of antitubercular drug-loaded surfactants as inhalable drug-delivery systems for pulmonary tuberculosis.
Chimote G; Banerjee R
J Biomed Mater Res A; 2009 May; 89(2):281-92. PubMed ID: 18431766
[TBL] [Abstract][Full Text] [Related]
4. Effects of albumin and erythrocyte membranes on spread monolayers of lung surfactant lipids.
Rachana R; Banerjee R
Colloids Surf B Biointerfaces; 2006 Jun; 50(1):9-17. PubMed ID: 16650737
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of antitubercular drug insertion into preformed dipalmitoylphosphatidylcholine monolayers.
Chimote G; Banerjee R
Colloids Surf B Biointerfaces; 2008 Apr; 62(2):258-64. PubMed ID: 18082382
[TBL] [Abstract][Full Text] [Related]
6. Molecular interactions of cord factor with dipalmitoylphosphatidylcholine monolayers: implications for lung surfactant dysfunction in pulmonary tuberculosis.
Chimote G; Banerjee R
Colloids Surf B Biointerfaces; 2008 Aug; 65(1):120-5. PubMed ID: 18455914
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of inhalable isoniazid-loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis.
Chimote G; Banerjee R
J Biomed Mater Res B Appl Biomater; 2010 Jul; 94(1):1-10. PubMed ID: 20524179
[TBL] [Abstract][Full Text] [Related]
8. Effects of eicosane, a component of nanoparticles in diesel exhaust, on surface activity of pulmonary surfactant monolayers.
Kanno S; Furuyama A; Hirano S
Arch Toxicol; 2008 Nov; 82(11):841-50. PubMed ID: 18488198
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the in situ structural and interfacial properties of the cationic hydrophobic heteropolypeptide, KL4, in lung surfactant bilayer and monolayer models at the air-water interface: implications for pulmonary surfactant delivery.
Mansour HM; Damodaran S; Zografi G
Mol Pharm; 2008; 5(5):681-95. PubMed ID: 18630875
[TBL] [Abstract][Full Text] [Related]
10. Hysteresis behavior of amphiphilic model peptide in lung lipid monolayers at the air-water interface by an IRRAS measurement.
Nakahara H; Dudek A; Nakamura Y; Lee S; Chang CH; Shibata O
Colloids Surf B Biointerfaces; 2009 Jan; 68(1):61-7. PubMed ID: 18977123
[TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics simulations of lung surfactant lipid monolayers.
Rose D; Rendell J; Lee D; Nag K; Booth V
Biophys Chem; 2008 Dec; 138(3):67-77. PubMed ID: 18845376
[TBL] [Abstract][Full Text] [Related]
12. New protocols for preparing dipalmitoylphosphatidylcholine dispersions and controlling surface tension and competitive adsorption with albumin at the air/aqueous interface.
Kim SH; Franses EI
Colloids Surf B Biointerfaces; 2005 Jul; 43(3-4):256-66. PubMed ID: 15979858
[TBL] [Abstract][Full Text] [Related]
13. Effect of D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) on surfactant monolayers.
Shah AR; Banerjee R
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):116-24. PubMed ID: 21398100
[TBL] [Abstract][Full Text] [Related]
14. Effect of calcium on the surface properties of phospholipid monolayers with respect to surfactant formulations in respiratory distress syndrome.
Banerjee R; Bellare J
Biomed Mater Eng; 2001; 11(1):43-53. PubMed ID: 11281578
[TBL] [Abstract][Full Text] [Related]
15. Effect of mycolic acid on surface activity of binary surfactant lipid monolayers.
Chimote G; Banerjee R
J Colloid Interface Sci; 2008 Dec; 328(2):288-98. PubMed ID: 18848703
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and interfacial behavior of sulfur-containing analogs of lung surfactant dipalmitoyl phosphatidylcholine.
Chang Y; Wang Z; Notter RH; Wang Z; Qu L; Schwan AL
Bioorg Med Chem Lett; 2004 Dec; 14(24):5983-6. PubMed ID: 15546713
[TBL] [Abstract][Full Text] [Related]
17. Interfacial organizations of gel phospholipid and cholesterol in bovine lung surfactant films.
Nag K; Fritzen-Garcia M; Devraj R; Panda AK
Langmuir; 2007 Apr; 23(8):4421-31. PubMed ID: 17341098
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics study of the effect of cholesterol on the properties of lipid monolayers at low surface tensions.
Laing C; Baoukina S; Tieleman DP
Phys Chem Chem Phys; 2009 Mar; 11(12):1916-22. PubMed ID: 19280002
[TBL] [Abstract][Full Text] [Related]
19. Interactions between hematological derivatives and dipalmitoyl phosphatidyl choline: implications for adult respiratory distress syndrome.
Banerjee RR
Colloids Surf B Biointerfaces; 2004 Mar; 34(2):95-104. PubMed ID: 15261079
[TBL] [Abstract][Full Text] [Related]
20. Artificial pulmonary surfactant as a carrier for intratracheally instilled insulin.
Ji Y; Liu C; Pei YY
Acta Pharmacol Sin; 2007 May; 28(5):744-50. PubMed ID: 17439732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
